Elemental Healthcare to distribute GI Dynamics'
gastrointestinal liner in UK
9 Sept 2010
GI Dynamics has licensed Hungerford-based Elemental Healthcare
to distribute its EndoBarrier Gastrointestinal Liner in
England, Wales, Scotland, Northern Ireland and Ireland.
The EndoBarrier, a non-surgical therapeutic, has received European
approval for the treatment of type 2 diabetes and obesity and will be
commercialized in certain markets later this year.
“GI Dynamics is very pleased to establish this partnership with
Elemental Healthcare, a premier medical device distribution
organization in the UK,” stated Stuart A Randle, chief executive
officer of GI Dynamics. “Elemental Healthcare’s proven sales track
record, and experience in the diabetes and obesity markets and with
bringing minimally invasive products to healthcare providers and
surgeons, will be invaluable as the EndoBarrier becomes commercially
available in select markets later this year.”
In preparation for the European launch of the EndoBarrier, GI
Dynamics and Elemental Healthcare are identifying, training and
designating Centers of Excellence and expanding clinical experience
with the EndoBarrier.
The Centres of Excellence participating in
this effort in the UK include St Anthony’s Hospital, Imperial
College/St Mary’s Hospital, National Obesity Surgery Centre
(Manchester) and Southampton University Hospital. Designated Centres
of Excellence will have exclusive access over the next several
months to the EndoBarrier as a cornerstone of an overall patient
care program to treat patients with type 2 diabetes and obesity.
Adam Power, managing director, Elemental Healthcare commented,
“The epidemic of type 2 diabetes and obesity is an issue that cannot
afford to be ignored and EndoBarrier addresses both of these
concerns. We are excited about our partnership with GI Dynamics and
proud that we can now offer UK and Northern Ireland-based
physicians the most advanced non-surgical technology available on